Cargando…
Detection of cancer cells using SapC-DOPS nanovesicles
Unlike normal cells, cancer cells express high levels of phosphatidylserine on the extracellular leaflet of their cell membrane. Exploiting this characteristic, our lab developed a therapeutic agent that consists of the fusogenic protein, saposin C (SapC) which is embedded in dioleoylphosphatidylser...
Autores principales: | Davis, Harold W., Hussain, Nida, Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862232/ https://www.ncbi.nlm.nih.gov/pubmed/27160923 http://dx.doi.org/10.1186/s12943-016-0519-1 |
Ejemplares similares
-
Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013) -
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2019) -
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020) -
SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
por: N’Guessan, Kombo F., et al.
Publicado: (2020) -
Correction: Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
Publicado: (2015)